Business Description
Hinova Pharmaceuticals Inc
ISIN : CNE1000059F5
Share Class Description:
SHSE:688302: Class ACompare
Compare
Traded in other countries / regions
688302.China IPO Date
2022-04-12Description
Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 78.64 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.4 | |||||
| 3-Year EPS without NRI Growth Rate | 24.7 | |||||
| 3-Year FCF Growth Rate | -0.7 | |||||
| 3-Year Book Growth Rate | 1.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.92 | |||||
| 9-Day RSI | 57.43 | |||||
| 14-Day RSI | 53.52 | |||||
| 6-1 Month Momentum % | -41.97 | |||||
| 12-1 Month Momentum % | -61.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.83 | |||||
| Quick Ratio | 11.83 | |||||
| Cash Ratio | 11.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 0.91 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -18.77 | |||||
| ROA % | -17.01 | |||||
| ROIC % | -96.29 | |||||
| ROC (Joel Greenblatt) % | -162.26 | |||||
| ROCE % | -18.44 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.29 | |||||
| Price-to-Tangible-Book | 2.3 | |||||
| EV-to-EBIT | -7.23 | |||||
| EV-to-EBITDA | -7.23 | |||||
| EV-to-FCF | -5.36 | |||||
| Price-to-Net-Current-Asset-Value | 3.09 | |||||
| Price-to-Net-Cash | 3.27 | |||||
| Earnings Yield (Greenblatt) % | -13.83 | |||||
| FCF Yield % | -11.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hinova Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | |||
| EPS (TTM) (Â¥) | -2.696 | ||
| Beta | 0 | ||
| Volatility % | 38.02 | ||
| 14-Day RSI | 53.52 | ||
| 14-Day ATR (Â¥) | 1.57298 | ||
| 20-Day SMA (Â¥) | 28.957 | ||
| 12-1 Month Momentum % | -61.26 | ||
| 52-Week Range (Â¥) | 23.96 - 70.7 | ||
| Shares Outstanding (Mil) | 99.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hinova Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hinova Pharmaceuticals Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hinova Pharmaceuticals Inc Frequently Asked Questions
What is Hinova Pharmaceuticals Inc(SHSE:688302)'s stock price today?
The current price of SHSE:688302 is ¥30.10. The 52 week high of SHSE:688302 is ¥70.70 and 52 week low is ¥23.96.
When is next earnings date of Hinova Pharmaceuticals Inc(SHSE:688302)?
The next earnings date of Hinova Pharmaceuticals Inc(SHSE:688302) is .
Does Hinova Pharmaceuticals Inc(SHSE:688302) pay dividends? If so, how much?
Hinova Pharmaceuticals Inc(SHSE:688302) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers